Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda

BACKGROUND: The Global Laboratory Initiative (GLI) guidelines recommend repeat for GeneXpertMTB/RIF (XpertMTB/RIF) in patients with a low pretest probability of rifampicin resistance (RR). METHODS: This was a cross-sectional study using results of sputum specimens collected from participants screene...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Open Forum Infect Dis
Päätekijät: Ssengooba, Willy, de Dieu Iragena, Jean, Komakech, Kevin, Okello, Iginitius, Nalunjogi, Joanitah, Katagira, Winceslaus, Kimuli, Ivan, Adakun, Susan, Joloba, Moses L, Torrea, Gabriela, Kirenga, Bruce J
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2021
Aiheet:
Major Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8223903/
https://ncbi.nlm.nih.gov/pubmed/34189166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab173
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia